Brief: Sienna Biopharmaceuticals Reports Q4 Loss Per Share Of $0.93
14/03/2019 13:09
March 14 (Reuters) - Sienna Biopharmaceuticals Inc SNNA.O :
* SIENNA BIOPHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL
YEAR
2018 FINANCIAL RESULTS
* SIENNA BIOPHARMACEUTICALS INC - QTRLY LOSS PER SHARE $0.93
* SIENNA BIOPHARMACEUTICALS INC - CASH AND CASH EQUIVALENTS
AS OF
DEC. 31, 2018, TOTALED APPROXIMATELY $48.5 MILLION
Source text for Eikon: ID:nGNX33G8RN
Further company coverage: SNNA.O
(Reuters.Briefs@thomsonreuters.com)
Recent news on Sienna Biopharmaceuticals
See all newsU.S. STOCKS ON THE MOVE-Adobe, Oracle, Snap, Phreesia, Sarepta, Aquestive Therapeutics, Patterson-UTI
U.S. STOCKS ON THE MOVE-Lululemon, GE, Starbucks, Delta Air Lines, Lumber Liquidators, Lovesac
Sienna Biopharma: Falls on Nasdaq delisting plans
Brief: Sienna Biopharma Says Bankruptcy Court Approved Sale Of Assets Related To SNA-001 For $1.7 Mln In Cash
Brief: Sienna Biopharmaceuticals Announces Court Approval Of Chapter 11 Bidding Procedures